Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

5.240 -0.250 (-4.55%)
Streaming Delayed Price Updated: 11:14 AM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 387,403
Open 5.460
Bid (Size) 5.200 (1)
Ask (Size) 5.240 (2)
Prev. Close 5.490
Today's Range 5.021 - 5.530
52wk Range 1.550 - 16.33
Shares Outstanding 29,940,637
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Adds Approximately 1.2 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire

Performance

YTD
+187.91%
+187.91%
1 Month
+187.91%
+187.91%
3 Month
+62.73%
+62.73%
6 Month
-35.71%
-35.71%
1 Year
-59.09%
-59.09%

More News

Read More
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
DermTech Earnings Perspective: Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run
Via The Motley Fool
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
Via Benzinga
US Stocks Open Higher; Nasdaq Rises 50 Points
Via Benzinga
DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by TRICARE
From DermTech, Inc.
Via Business Wire
DermTech Adds Approximately 13 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
From DermTech, Inc.
Via Business Wire
Analyst Ratings for DermTech
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
DermTech Reports Third-Quarter 2022 Financial Results
From DermTech, Inc.
Via Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.